Skip to main content

Latest Market News — Page 107

Page 107 · 30 stories scored 7+ · newest 7:32 AM ET · How scores work

Mon, Aug 1730 stories
7ALMAlmonty Industries Inc.Almonty Launches $300M Share Buyback, Signaling Cash StrengthFinancing · Reuters▲ Positive8LHXL3Harris Technologies, Inc.L3Harris Reaffirms 2026 Guidance Hours After CEO DepartureEarnings & guidance · Dow Jones Newswires● NeutralPro7FTHFaeth Therapeutics, Inc.FDA Grants Fast Track to Faeth's Piktor Combo in Endometrial CancerProduct & regulatory · Reuters▲ Positive7ZENAZenaTech, Inc.U.S. Tariffs on Imported Drones Could Give ZenaDrone a Competitive EdgeProduct & regulatory · GlobeNewswire▲ Positive7BDNBrandywine Realty TrustBrandywine Launches $100M Debt Tender Offer for 2028 and 2029 NotesFinancing · GlobeNewswire● Neutral7AWKAmerican Water Works Company, Inc.American Water-Essential Utilities Merger Clears HSR Antitrust ReviewM&A & partnerships · PR Newswire▲ Positive7MLYSMineralys Therapeutics, Inc.Mineralys Reports Pivotal BP Trial Wins and $200M Tanabe License AmendmentProduct & regulatory · Wiseek News▲ Positive7ISSCINNOVATIVE SOLUTIONS & SUPPORT INCISSC Secures >$50M eVTOL Avionics Deal, Cash Flow Surges 155%Earnings & guidance · Wiseek News▲ Positive7EDBLEdible Garden AG IncEdible Garden H1 Revenue Jumps 17.5%, Loss Narrows as RTD Prototypes FinishEarnings & guidance · Wiseek News▲ Positive7DYAIDyadic International, Inc.Dyadic H1 Revenue Up 52% But Losses Widen; $2.9M Share Sale to Fund OperationsEarnings & guidance · Wiseek News▼ Negative7CREXCreative Realities, Inc.Q2 Loss and EPS Miss Overshadow 65% Revenue Surge and $4M ARR PipelineEarnings & guidance · Wiseek News▼ Negative7CAPRCAPRICOR THERAPEUTICS, INC.Cantor Upgrades Capricor to Overweight, PT $28, After HOPE-3 Success and $238M CashEarnings & guidance · Wiseek News▲ Positive7KPLTKatapult Holdings, Inc.Katapult Secures $200M Term Loan to Refinance Post-Merger DebtFinancing · Wiseek News▲ Positive7NEENextEra Energy, Inc.NextEra Adds $1.15B Symmetry Energy Buy, Details Two-Step Dominion MergerM&A & partnerships · Wiseek News▲ Positive8KKRKKR & Co. Inc.KKR Files Mandatory Offer for First Gen at ₱165.44B, Joins Medallia Creditor TakeoverM&A & partnerships · Wiseek News▲ PositivePro7DISWalt Disney CoDisney CEO Calls Stock Weak, Floats ESPN Spinoff as Analysts Push for BreakupGovernance · Wiseek News● Neutral7HRTXHeron Therapeutics, Inc.Heron Withdraws 2026 Guidance as CINVANTI Patent Loss Clouds OutlookEarnings & guidance · Wiseek News▼ Negative7APOApollo Global Management, Inc.Apollo Sets 2029 Targets: $275B Origination, $150B Capital RaisedM&A & partnerships · Wiseek News▲ Positive7OTLKOutlook Therapeutics, Inc.Outlook Therapeutics Plans $55M Offering at $0.99 to Fund LYTENAVA LaunchFinancing · Wiseek News▼ Negative7XLOXilio Therapeutics, Inc.Xilio Q2 Revenue Jumps 131% to $18.7M, FDA Clears XTX501 INDEarnings & guidance · Wiseek News▲ Positive7MSFTMICROSOFT CORPMicrosoft Readies Maia 300 AI Chips, Deploys 50MW AI Cloud UnitsProduct & regulatory · Wiseek News▲ Positive7ALHAlliance Laundry Holdings Inc.Principal Stockholder to Sell 20.5M Shares; Company to Repurchase $75M ConcurrentlyFinancing · BusinessWire● Neutral8ADILADIAL PHARMACEUTICALS, INC.Adial Q2 Loss Per Share Misses by 10x on $46M Acquisition ChargeEarnings & guidance · Reuters▼ NegativePro8PROPPrairie Operating Co.Prairie Operating Q2 Revenue Beats, Guides 2026 EBITDA Up to $190MEarnings & guidance · Reuters▲ PositivePro7OABIOmniAb, Inc.OmniAb Inks Ion Channel Discovery Deal With Eli Lilly, Up to $370M in MilestonesM&A & partnerships · Dow Jones Newswires▲ Positive8FULCFulcrum Therapeutics, Inc.Fulcrum to Merge with Slate Medicines in Pivot to Migraine TherapiesM&A & partnerships · Dow Jones Newswires● NeutralPro7AUAngloGold Ashanti PLCAngloGold Ashanti Boosts Stake in Thesis Gold & Silver via C$58.5M OfferingFinancing · Dow Jones Newswires▲ Positive7NRXPNRX Pharmaceuticals, Inc.NRx Pharmaceuticals Q2: FDA Ketamine Review Clears Major Hurdle, Cash Runway Extended to One YearEarnings & guidance · GlobeNewswire▲ Positive9EYPTEyePoint, Inc.EyePoint's DURAVYU Misses Primary Endpoint in LUGANO, But Shows Strong Secondary BenefitsProduct & regulatory · GlobeNewswire▼ NegativePro7AMPGAmpliTech Group, Inc.AmpliTech Sees 2026 Revenue Growth, $17M Backlog, and Tier-1 RFP OpportunityEarnings & guidance · GlobeNewswire▲ Positive
How Wiseek picks and scores these

How Wiseek curates this list

Every entry started life as licensed wire-service reporting (Reuters, Dow Jones Newswires, and similar publishers) covering ticker-attributable events. Wiseek's editorial pipeline ingests these in real time, runs each headline through our domain-tuned importance scorer, and surfaces only items rated 7 or higher on a 1–10 market-impact scale. Items below 7 are filtered out at the database query so the public feed stays signal-dense.

What "AI-ranked analysis" means

For each item we publish a plain-English summary, a sentiment label (positive / negative / neutral), and a structured list of key events extracted from the underlying source. Score, summary, and sentiment come from Wiseek's in-house models — not generic chatbot output. See our methodology for the full pipeline and our editorial policy for source-attribution standards.

What's not on this page

Generic market commentary, opinion columns, low-impact press releases, and items below the 7-point importance threshold. Wiseek aggregates and scores wire-service headlines; the underlying publishers retain their original reporting and are credited per article.

Track by company

Follow SEC filings and market news for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.